A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy
- PMID: 35074337
- PMCID: PMC8780055
- DOI: 10.1016/j.ajog.2022.01.018
A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy
References
-
- Khan D.S.A., Pirzada A.N., Ali A., Salam R.A., Das J.K., Lassi Z.S. The differences in clinical presentation, management, and prognosis of laboratory-confirmed COVID-19 between pregnant and non-pregnant women: a systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18:5613. - PMC - PubMed
-
- Mayer C., VanHise K., Caskey R., Naqvi M., Burwick R.M. Monoclonal antibodies Casirivimab and Imdevimab in pregnancy for coronavirus disease 2019 (COVID-19) Obstet Gynecol. 2021;138:937–939. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical